SCIENCE IN THE NEWS DAILY
In Study, Drug Delays Worsening of Breast Cancer, With Fewer Side Effects
from the New York Times (Registration Required)
CHICAGO -- A drug that delivers a powerful poison to tumors without some of the side effects of traditional treatments can delay the worsening of breast cancer and also appears to substantially prolong lives, according to results of a study presented here [the American Society of Clinical Oncology] Saturday.
Besides representing an advance in treating breast cancer, the success in the clinical trial validates an idea that is now being pursued by numerous pharmaceutical companies to treat various types of cancer in a way that delivers drugs to cancerous cells while sparing healthy ones.
"We've envisioned a world where cancer treatment would kill the cancer and not hurt the patient," Dr. Kimberly L. Blackwell, a professor of medicine at the Duke Cancer Institute and the lead investigator in the trial, said in an interview. "And this drug does that."
Connect With Us:
PODCASTS: From Balloons to Space Stations: Studying Cosmic Rays
Cosmic rays have mysterious qualities about them that scientists continue to research in order to better understand their origins and composition. Dr. Eun-Suk Seo, a professor of physics at the University of Maryland, and her colleagues, fly enormous balloons as large as a football stadium and a volume of 40-million-cubic feet for extended periods over Antarctica to study particles coming from cosmic rays before they break up in the atmosphere.
To view all multimedia content, click "Latest Multimedia."
Receive notification when new content is posted from the entire website, or choose from the customized feeds available.